En este subanlisis, semaglutida demostr beneficios renales en personas con obesidad y riesgo cardiovascular alto, pero sin DM2, reduciendo de manera significativa los eventos adversos renales (semaglutida [1,8%] frente a placebo [2,2%]) y desacelerando la cada del filtrado glomerular (semaglutida 0,78 frente a placebo 1,17ml/min/1,73m2/ao)
MeAgain brings those habits into a daily GLP-1 companion experience: injection-site history, shot-day rhythm, food, protein, fiber, water, progress photos, symptom patterns, estimated medication levels, Journey Card, and Capy
From GLP-1 receptor-agonist meds like Ozempic or Wegovy and GLP-1/GIP dual agonists to the triple agonists on the horizonit can get confusing
The ripple effects across multiple industries are only beginning to emerge
When NNMT is active, it methylates nicotinamide (a form of vitamin B3), making it unavailable for conversion into NAD a crucial molecule for energy production and cellular repair